A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- COMBINATION_PRODUCT: CD388 Injection
- COMBINATION_PRODUCT: Placebo
Sponsor
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)